90 citations
,
May 2018 in “Molecular Cell” Caspase-3 helps control cell growth and organ size by activating YAP.
11 citations
,
August 2024 in “Nature Communications” In this study, researchers observed that quiescent mouse embryonic fibroblasts showed reduced glycolysis but increased TCA cycle flux and mitochondrial respiration, with these changes linked to metabolic reprogramming involving yes-associated protein inhibition and malate cycle modulation, which supports extracellular matrix protein synthesis.
This study introduced fibronectin nanogel microneedles (FNG MNs) that demonstrated improved tissue penetration and transdermal delivery, restoring skin homeostasis in a photoaged mouse model and enhancing collagen deposition and angiogenesis in a diabetic wound rat model.
June 2026 in “ACS Nano Medicine” The study presents the development of fibronectin nanogel microneedles (FNG MNs) designed to enhance tissue penetration and transdermal delivery for anti-aging and diabetic wound healing applications. The FNG MNs, with an average size of 82.0 nm, demonstrate excellent stability, cytocompatibility, and cell penetration capabilities. In a photoaged mouse model, these microneedles effectively restore skin homeostasis by normalizing epidermal thickness, reorganizing collagen and elastin fibers, and reducing inflammation and oxidative stress. In a diabetic wound rat model, FNG MNs promote collagen deposition, hair follicle neogenesis, and angiogenesis while reducing Yes-associated protein expression. These findings suggest that FNG MNs could be a promising formulation for various biomedical applications due to their ability to modulate the extracellular matrix, reduce inflammation, and provide antioxidative benefits.
October 2025 in “Clinical Cosmetic and Investigational Dermatology” This study synthesizes knowledge of how dendritic cell signals, epithelial integrins, and fibroblast activity converge on TGF-β1 to maintain or disrupt skin healing, contrasting normal and fibrotic scar formation and suggesting possible integrin and immune-targeted treatments for skin fibrosis.